LINC-ROR and breast carcinoma: Then, transwell assays indicated that the overexpression of miR‐194‐3p inhibited the migration (Fig. 10B,C) and invasion (Fig. 10D,E) abilities of breast cancer cells, and reduced the effect of linc‐ROR on promoting these abilities.